Exploring glyco-signatures and their clinical implications:a special issue focused on glycosylation studies  

作　　者：Haojia Lu Xing Chen 

机构地区：[1]Institutes of Biomedical Sciences and Liver Cancer Institute,Zhongshan Hospital,Fudan University,Shanghai 200032,China [2]Department of Chemistry and NHC Key Laboratory of Glycoconjugates Research,Fudan University,Shanghai 200433,China [3]College of Chemistry and Molecular Engineering,Peking University,Beijing 100871,China [4]Beijing National Laboratory for Molecular Sciences,Peking University,Beijing 100871,China [5]Peking-Tsinghua Center for Life Sciences,Peking University,Beijing 100871,China [6]Synthetic and Functional Biomolecules Center,Peking University,Beijing 100871,China [7]Key Laboratory of Bioorganic Chemistry and Molecular Engineering of Ministry of Education,Peking University,Beijing 100871,China

出　　处：《Acta Biochimica et Biophysica Sinica》2024年第8期1097-1098,共2页生物化学与生物物理学报（英文版）

摘　　要：Glycosylation is one of the most common post-translational modifications,playing a crucial role in various physiological and pathological processes.An increasing number of studies suggest that research on glycosylation holds promise for the development of clinical diagnostic biomarkers and therapeutic targets.This special issue combines four research studies and eight reviews that cover a vast range of topics within glycosylation research field,contributed by specialists in the field from various regions and countries.

关 键 词：CLINICAL SIGNATURE holds 

分 类 号：Q53[生物学—生物化学]